Legal Representation
Attorney
S. Myers Dill
USPTO Deadlines
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 2, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 2, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 30, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 4, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 4, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 15, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 26, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 2, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 2, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 29, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 25, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 10, 2019 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| Mar 10, 2019 | EPEN | O | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | Loading... |
| Mar 10, 2019 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Mar 10, 2019 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Mar 4, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 20, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 6, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and biological preparations used in the treatment of cancer; pharmaceutical and biological preparations used in active specific immunotherapy for the treatment of cancer
First Use Anywhere:
0
First Use in Commerce:
0
Class 016
Publications, namely, printed research papers and articles in the fields of pharmaceuticals, biologicals, and clinical trials
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research in the fields of pharmaceutical and biological preparations used in the treatment of cancer and pharmaceutical and biological preparations used in active specific immunotherapy for the treatment of cancer; providing on-line, non-downloadable scientific and medical research information in the fields of pharmaceuticals, biologicals, and clinical trials
First Use Anywhere:
Nov 27, 2018
First Use in Commerce:
Nov 27, 2018
Classification
International Classes
005
016
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"